NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for placebo


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
Data on psychopharmacology described by T.P. Freeman et al
2009 NOV 28 ... conditioning task, experiment 1 assessed healthy volunteers before and during placebo (n = 16), low-dose (n = 15), and high-dose ketamine (n = 16) under randomized and ...
Subject: Psychopharmacology
Price: $3.00
*
Despite some benefit, drug ads can be harmful to your health
2009 NOV 28 ... precise quantitative information. The ads should state how this drug compared to placebo or other available treatments, including generic drugs. Ads should provide ...
Subject: IQ Solutions, Inc.
Price: $3.00
*
Neurogen Corporation Announces Third Quarter 2009 Financial Results and Updates Operations
2009 NOV 25 ... announced merger into Ligand. Aplindore This Phase 2 RLS study was a randomized, placebo-controlled, double-blind, multi-center, parallel-group study designed to assess the ...
Subject: Neurogen Corporation
Price: $3.00
*
New findings from University of Alabama in the area of science published
2009 NOV 26 ... in the dietary management of knee osteoarthritis. The 12-week, randomized, double-blind, placebo-controlled trial in an academic medical center enrolled 59 patients with moderate ...
Subject: Science
Price: $3.00
*
New science study findings reported from Harokopio University
2009 NOV 26 ... its antioxidant effects if consumed on a daily basis by healthy subjects. In this placebo-controlled clinical trial, 63 subjects were recruited for a 1-month nutritional ...
Subject: Science
Price: $3.00
*
New surgery findings from Shriners Hospital for Children described
2009 NOV 25 ... scientists in the United States report. "were randomized to receive either placebo (n = 94) or long-term rhGH at 0.05, 0.1, or 0.2 mg/kg/d (n = 101) Changes in weight, ...
Subject: Surgery
Price: $3.00
*
Popular anti-platelet therapy reduces risk of cardiovascular events in men and women
2009 NOV 29 ... 30 percent of whom were women. Lead investigators of the five double-blinded, randomized placebo-controlled trials shared original study data with authors.Clopidogrel works ...
Subject: American College of Cardiology
Price: $3.00
*
Research in the area of pediatrics reported from Bristol-Myers Squibb Company
2009 NOV 28 ... of these symptoms, were randomized 1:1:1:1 to aripiprazole (5, 10, or 15 mg/day) or placebo in this 8-week double-blind, randomized,...
Subject: Pediatrics
Price: $3.00
*
Studies from Children's Hospital in the area of life sciences described
2009 NOV 26 ... with the intention of preventing urinary tract infection, but adequately powered, placebo-controlled trials regarding efficacy are lacking. This study from four Australian ...
Subject: Life Sciences
Price: $3.00
*
Studies from H. Amagase and co-researchers in the area of science published
2009 NOV 26 ... mL/day, equivalent to at least 150 g of fresh fruit, the amount traditionally used, or placebo for 30 days in a randomized, double-blind,...
Subject: Science
Price: $3.00
*
Studies from Harokopio University yield new information about food microbiology
2009 NOV 26 ... According to a study from Athens, Greece, "In this randomized, double-blinded, placebo-controlled clinical study we aimed to evaluate the in vivo prebiotic effects of a ...
Subject: Food Microbiology
Price: $3.00
*
Study data from X.Q. Luo and colleagues update understanding of pharmaceuticals
2009 NOV 23 ... "The specificity of the method was validated by assessing interference from the placebo and by forced degradation. The method has demonstrated good linearity (r = 0.9998), ...
Subject: Pharmaceuticals
Price: $3.00
*
Study data from Y. Tominaga et al provide new insights into surgery
2009 NOV 25 ... and reduce mortality. However, we do not have reliable evidence that PTx compared with placebo or active drugs, improves mortality or outcome with respect to cardiovascular symptoms, ...
Subject: Surgery
Price: $3.00
*
Study results from University of California, Medical Department update understanding of breast cancer
2009 NOV 23 ... equine estrogens, 0.625 mg, plus medroxyprogesterone acetate, 2.5 mg (n = 8506), or placebo (n = 8102). At baseline and annually, participants under-went mammography and clinical ...
Subject: Breast Cancer
Price: $3.00
*
Teva Files Amended Complaint Against Momenta/Sandoz to Include Infringement of Three COPAXONE(R)-Related Patents
2009 NOV 23 ... or 505(b)(2) application, should conduct pre-clinical testing as well as full-scale, placebo-controlled clinical trials with measured clinical endpoints in MS patients to establish ...
Subject: Teva Pharmaceutical Industries Ltd.
Price: $3.00
*
The narrow line between love and jealousy
2009 NOV 23 ... inhaled the synthetic form of the hormone in the first session and were given a placebo (a dummy drug) in the second session; the others were given a...
Subject: University of Haifa
Price: $3.00
*
Tobira Therapeutics Announces Presentation of TBR-652 Data at European AIDS Conference
2009 NOV 23 ... infectious diseases, announced pharmacokinetic data and results from two double-blind, placebo-controlled studies of TBR-652 in eighty-four healthy volunteers. The two studies, a ...
Subject: Pharmacokinetics
Price: $3.00
*
University of Calgary details research in syncope
2009 NOV 23 ... effectiveness in preventing syncope. The Prevention of Syncope Trial was a randomized, placebo-controlled, double-blind, multinational, clinical trial that tested the hypothesis that ...
Subject: Syncope
Price: $3.00
*
University of Pittsburgh, Western Psychiatric Institute details research in cancer epidemiology
2009 NOV 23 ... beta 2 subunit (CHRNB2) gene with quitting success in response to nicotine versus placebo patch during a short-term test of patch effects," researchers in the United States ...
Subject: Cancer Epidemiology
Price: $3.00
*
Vacationing in Thailand over Greece? That's the dopamine talking
2009 NOV 24 ... gave the participants either L-DOPA (a drug that increases dopamine concentrations) or a placebo and asked them to imagine vacationing in those destinations. The next day, participants ...
Subject: Research
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login